Alkem Laboratories Ltd (BOM:539523)
₹ 5501.35 -117.95 (-2.1%) Market Cap: 658.01 Bil Enterprise Value: 629.50 Bil PE Ratio: 32.04 PB Ratio: 6.38 GF Score: 98/100

Q2 2024 Alkem Laboratories Ltd Earnings Call Transcript

Nov 07, 2023 / 12:00PM GMT
Release Date Price: ₹4026.9 (+5.34%)
Operator

Ladies and gentlemen, good day, and welcome to Alkem Laboratories Q2 FY '24 Earnings Conference Call. (Operator Instructions) Please note that this conference is being recorded.

And now I will hand the conference over to Mr. Tushar from Motilal Oswal Financial Services. Thank you, and over to you, sir.

Tushar Manudhane
Motilal Oswal Securities Limited, Research Division - Research Analyst

Yes. Thank you, Sheela. Welcome to 2Q FY '24 Earnings Call of Alkem Laboratories. From management side, we have Mr. Sandeep Singh, Managing Director; Dr. Vikas Gupta, CEO; Mr. Rajesh Dubey, Chief Financial Officer; Mr. Amit Ghare, President, International Business; and Amit Khandelia, VP Finance. Over to you Amit.

Amit Kumar Khandelia
Alkem Laboratories Limited - IR Officer

Thank you, Tushar. Good evening, everyone, and thank you for joining us today for Alkem Laboratories Q2 FY '24 Earnings Call. Earlier during the day, we have released our financial results and investor presentation and the same are also posted on our

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot